Apyx Medical Corp (APYX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20M 40M 60M Q3 '21: 43.2M Q4 '21: 48.5M Q1 '22: 52.4M Q2 '22: 51.4M Q3 '22: 48.7M Q4 '22: 44.5M Q1 '23: 44.2M Q2 '23: 47.4M Q3 '23: 50.3M Q4 '23: 52.3M Q1 '24: 50.5M Q2 '24: 49M Q3 '24: 48.5M Q4 '24: 48.1M Q1 '25: 47.3M Q2 '25: 46.5M Q3 '25: 47.9M Q4 '25: 52.8M Q1 '26: 55.9M Q2 '26: 58.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '21: 29.2M Q4 '21: 33.6M Q1 '22: 36M Q2 '22: 35.3M Q3 '22: 33M Q4 '22: 29.1M Q1 '23: 28.5M Q2 '23: 30.9M Q3 '23: 33.1M Q4 '23: 33.8M Q1 '24: 32.1M Q2 '24: 30.3M Q3 '24: 29.3M Q4 '24: 29.4M Q1 '25: 29.1M Q2 '25: 28.7M Q3 '25: 30M Q4 '25: 33M Q1 '26: 35.3M Q2 '26: 37.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '21: -14.8M Q4 '21: -14.4M Q1 '22: -15.6M Q2 '22: -17.5M Q3 '22: -19.3M Q4 '22: -23.6M Q1 '23: -23.3M Q2 '23: -18.6M Q3 '23: -17.4M Q4 '23: -17.3M Q1 '24: -18.3M Q2 '24: -22.6M Q3 '24: -21.6M Q4 '24: -18.8M Q1 '25: -15.3M Q2 '25: -12.3M Q3 '25: -9.5M Q4 '25: -6.4M Q1 '26: -4.3M Q2 '26: -3.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-30M -20M -10M 0 10M 20M 30M Q3 '21: -14.7M Q4 '21: -15.2M Q1 '22: -16.2M Q2 '22: -17.6M Q3 '22: -19.1M Q4 '22: -23.2M Q1 '23: -20.7M Q2 '23: -16.3M Q3 '23: -15.2M Q4 '23: -18.7M Q1 '24: -22.8M Q2 '24: -28.4M Q3 '24: -28.4M Q4 '24: -23.5M Q1 '25: -20M Q2 '25: -17.3M Q3 '25: -14.5M Q4 '25: -11.2M Q1 '26: -9.2M Q2 '26: -8.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 8M 16M 24M Q3 '21: 14M Q4 '21: 14.9M Q1 '22: 16.4M Q2 '22: 16.1M Q3 '22: 15.7M Q4 '22: 15.4M Q1 '23: 15.7M Q2 '23: 16.6M Q3 '23: 17.2M Q4 '23: 18.6M Q1 '24: 18.3M Q2 '24: 18.7M Q3 '24: 19.2M Q4 '24: 18.7M Q1 '25: 18.2M Q2 '25: 17.8M Q3 '25: 17.9M Q4 '25: 19.8M Q1 '26: 20.6M Q2 '26: 21.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '21: -11.7M Q4 '21: -10.4M Q1 '22: -12.9M Q2 '22: -13.8M Q3 '22: -15.5M Q4 '22: -20.3M Q1 '23: -17.6M Q2 '23: -16.6M Q3 '23: -7.6M Q4 '23: -5.2M Q1 '24: -9.7M Q2 '24: -9.2M Q3 '24: -17.3M Q4 '24: -18M Q1 '25: -12.4M Q2 '25: -9.3M Q3 '25: -8.4M Q4 '25: -8M Q1 '26: -7.9M Q2 '26: -10.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-24M -16M -8M 0 8M 16M 24M Q3 '21: -12.5M Q4 '21: -11.2M Q1 '22: -13.7M Q2 '22: -15M Q3 '22: -16.7M Q4 '22: -21.3M Q1 '23: -18.5M Q2 '23: -17.2M Q3 '23: -8.1M Q4 '23: -5.8M Q1 '24: -10.2M Q2 '24: -9.8M Q3 '24: -17.9M Q4 '24: -18.8M Q1 '25: -13.2M Q2 '25: -10M Q3 '25: -9.5M Q4 '25: -9.1M Q1 '26: -9M Q2 '26: -11M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '18: 34.9M Q2 '20: 34.2M Q3 '20: 34.2M Q1 '21: 34.3M Q2 '21: 34.3M Q3 '21: 34.3M Q1 '22: 34.4M Q2 '22: 34.5M Q3 '22: 34.6M Q1 '23: 34.6M Q2 '23: 34.6M Q3 '23: 34.6M Q1 '24: 34.6M Q2 '24: 34.6M Q3 '24: 34.6M Q1 '25: 40.7M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 43.7M Q2 '26: 43.9M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '21: -0.43 Q4 '21: -0.44 Q1 '22: -0.47 Q2 '22: -0.51 Q3 '22: -0.56 Q4 '22: -0.67 Q1 '23: -0.60 Q2 '23: -0.47 Q3 '23: -0.43 Q4 '23: -0.54 Q1 '24: -0.66 Q2 '24: -0.82 Q3 '24: -0.83 Q4 '24: -0.67 Q1 '25: -0.55 Q2 '25: -0.45 Q3 '25: -0.36 Q4 '25: -0.27 Q1 '26: -0.22 Q2 '26: -0.20 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.